SCHEMBL1006523

SCHEMBL1006523

O=C(O)/C=C/c1ccccc1Oc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 1.00
▸ GAA P10253 2/20 0.79
▸ LMNA P02545 3/20 0.73
▸ SMN1; SMN2 Q16637 1/20 0.72
▸ MAPT P10636 3/20 0.60
▸ PLA2G1B P04054 1/20 0.60
▸ ATG4B Q9Y4P1 1/20 0.60
▸ KMT2A Q03164 1/20 0.59
▸ TLR4 O00206 1/20 0.57
▸ TLR2 O60603 1/20 0.57
▸ PTGER1 P34995 1/20 0.56
▸ PTGER4 P35408 1/20 0.56
▸ PTGER3 P43115 1/20 0.56
▸ PTGER2 P43116 1/20 0.56
▸ CA1 P00915 1/20 0.55
▸ CA2 P00918 1/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ CA4 P22748 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.54
▸ HPGD P15428 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714231 1.00 HTT (1.00) HTTGAALMNASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL11180824 0.98 HTT (0.97) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL8491329 0.89 HTT (0.81) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL8491325 0.89 HTT (0.81) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL8942449 0.89 HTT (0.79) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL8942446 0.89 HTT (0.79) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL9185939 0.86 HTT (0.76) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL30584121 0.86 HTT (0.76) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL9185934 0.86 HTT (0.76) HTTGAALMNASMN1; SMN2MAPT
SCHEMBL11180817 0.86 HTT (0.76) HTTGAALMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0053321-B1 SUBSTITUTED DERIVATIVES OF PHENOXY CINNAMIC ACID, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES BAYER AG (DE) 1985-05-29 — — EP claimed
US-4435208-A Herbicidally active substituted phenoxycinnamic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 1984-03-06 — — US claimed
EP-4553069-A1 ALPHA,ß-UNSATURATED AMIDE COMPOUND, AND PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2025-05-14 — — EP disclosed
CN-119790041-A Alpha, beta-unsaturated amide compounds, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2025-04-08 — — CN disclosed
CN-117402123-A Alpha, beta-unsaturated amide compounds, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-01-16 — — CN disclosed
CN-112204018-B Acrylic compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2023-08-29 — — CN disclosed
CN-112204018-A Acrylic acid compounds, preparation method thereof, pharmaceutical composition and application 中国科学院上海药物研究所 2021-01-08 — — CN disclosed
CN-110483432-A A kind of acrylic compounds and preparation method thereof, pharmaceutical composition and purposes UNIV FUDAN 2019-11-22 — — CN disclosed
US-20110092732-A1 APPLICATION OF IRIDIUM COMPLEXES IN ASYMMETRIC CATALYTIC HYDROGENATION OF UNSATURATED CARBOXYLIC ACIDS Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-04-21 — — US disclosed
EP-2275398-A1 APPLICATION OF THE IRIDIUM COMPLEX IN ASYMMETRIC CATALYTIC HYDROGENATION FOR UNSATURATED CARBOXYLIC ACID Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-01-19 — — EP disclosed
US-20030166590-A1 Microsomal triglyceride transfer protein WETTERAU JOHN R (US) 2003-09-04 — — US disclosed
EP-0643057-A1 Inhibitors of microsomal triglyceride transfer protein BRISTOL-MYERS SQUIBB COMPANY (US) 1995-03-15 — — EP disclosed
US-5250504-A Pre- and postemergence FMC CORPORATION (US) 1993-10-05 — — US disclosed
US-5242974-A Polymer formation on substrate with tether molecule, unmasking of protective group to form cyclic polymer, bond clevage AFFYMAX TECHNOLOGIES N.V. (NL) 1993-09-07 — — US disclosed
US-5198014-A Herbicidal beta-pyrazolylacrylic acid compound FMC CORPORATION (US) 1993-03-30 — — US disclosed
US-4540827-A Phenoxybenzene derivatives BAYER AKTIENGESELLSCHAFT (DE) 1985-09-10 — — US disclosed
US-4482736-A Herbicidally active substituted phenoxycinnamic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 1984-11-13 — — US disclosed
US-4482736-A Herbicidally active substituted phenoxycinnamic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 1984-11-13 — — US disclosed
US-4435208-A Herbicidally active substituted phenoxycinnamic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 1984-03-06 — — US disclosed
US-4435208-A Herbicidally active substituted phenoxycinnamic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 1984-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092732-A1 APPLICATION OF IRIDIUM COMPLEXES IN ASYMMETRIC CATALYTIC HYDROGENATION OF UNSATURATED CARBOXYLIC ACIDS HDHD5, ELOVL5, FASN HTT 4154/4885GAA 2005/4885LMNA 4812/4885
US-20030166590-A1 Microsomal triglyceride transfer protein MTTP, CETP, HDLBP HTT 1132/4885GAA 1215/4885LMNA 1381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback